Equity (Details Narrative) - USD ($) |
1 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Mar. 15, 2021 |
Feb. 11, 2021 |
Oct. 31, 2021 |
Oct. 20, 2021 |
Mar. 31, 2021 |
Feb. 28, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Common Shares Authorized | 200,000,000 | 200,000,000 | ||||||
| Intrinsic value | $ 445,290 | |||||||
| Preferred Shares Authorized | 1,000,000 | 1,000,000 | ||||||
| Granted Stock Option | 3,572 | 283,936 | 182,166 | 182,143 | 3,572 | 283,936 | ||
| Exercise price per share | $ 5.60 | $ 5.60 | $ 5.60 | $ 5.60 | $ 5.60 | $ 5.60 | ||
| ExpectedTerms | 3.0 | 3.0 | 3 | 3.0 | 3 | 3 years | ||
| stock-based compensation recognized | $ 473,144 | $ 9,860 | $ 604,571 | |||||
| Intrinsic Value Outstanding | $ 1,108,000 | |||||||
| Weighted average remaining term | 2 years 2 months 12 days | |||||||
| Maximum [Member] | ||||||||
| Reduction of the issued and outstanding shares | 152,573,743 | |||||||
| Options outstanding not exceed issued outstanding common shares | 10.00% | |||||||
| Minimum [Member] | ||||||||
| Reduction of the issued and outstanding shares | 10,898,408 | |||||||
| Options outstanding not exceed issued outstanding common shares | 5.00% | |||||||